(Q38366834)

2 September 2017

1 reference

title

Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze (English)

1 reference

invasive ductal carcinoma

2 September 2017

1 reference

1 reference

based on heuristic

inferred from title

pancreatic ductal adenocarcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal carcinoma

1 reference

Orianne Olivares

1

1 reference

2 September 2017

Sophie Vasseur

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

2 March 2015

1 reference

International Journal of Cancer

2 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 September 2017

volume

138

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

787-796

1 reference

2 September 2017

cites work

Cancer statistics, 2013

1 reference

European cancer mortality predictions for the year 2013.

21 January 2018

1 reference

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database

21 January 2018

1 reference

Genetics and biology of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

SnapShot: pancreatic cancer

21 January 2018

1 reference

Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?

21 January 2018

1 reference

Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer

21 January 2018

1 reference

Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.

21 January 2018

1 reference

Genetic progression of pancreatic cancer

21 January 2018

1 reference

Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype

21 January 2018

1 reference

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice

21 January 2018

1 reference

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

21 January 2018

1 reference

Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia

21 January 2018

1 reference

Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

21 January 2018

1 reference

Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia

21 January 2018

1 reference

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

21 January 2018

1 reference

Brief overview of selected approaches in targeting pancreatic adenocarcinoma

21 January 2018

1 reference

Tumor cell metabolism: cancer's Achilles' heel

21 January 2018

1 reference

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

Regulation of cancer cell metabolism

21 January 2018

1 reference

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

21 January 2018

1 reference

21 January 2018

1 reference

Defining the molecular basis of tumor metabolism: a continuing challenge since Warburg's discovery

21 January 2018

1 reference

On the Origin of Cancer Cells

21 January 2018

1 reference

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

HIF-1: upstream and downstream of cancer metabolism

21 January 2018

1 reference

Lactate: a metabolic key player in cancer

21 January 2018

1 reference

Mitochondria in cancer: not just innocent bystanders

21 January 2018

1 reference

A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth

21 January 2018

1 reference

Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells.

21 January 2018

1 reference

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

21 January 2018

1 reference

Changes in nutritional status associated with unresectable pancreatic cancer

21 January 2018

1 reference

Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients

21 January 2018

1 reference

Mechanisms of cancer cachexia

21 January 2018

1 reference

A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.

21 January 2018

1 reference

Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery

21 January 2018

1 reference

Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer

21 January 2018

1 reference

Metabolic system alterations in pancreatic cancer patient serum: potential for early detection

21 January 2018

1 reference

Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution

21 January 2018

1 reference

Specific amino acid profile in culture media conditioned by human pancreatic cancer cell lines

21 January 2018

1 reference

Alterations of metabolic genes and metabolites in cancer

21 January 2018

1 reference

Oncometabolites: linking altered metabolism with cancer

21 January 2018

1 reference

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

21 January 2018

1 reference

Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer

21 January 2018

1 reference

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

Pyruvate kinase M2 is a phosphotyrosine-binding protein

21 January 2018

1 reference

Quantitative proteomics: measuring protein synthesis using 15N amino acid labeling in pancreatic cancer cells

21 January 2018

1 reference

Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media

21 January 2018

1 reference

Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas

21 January 2018

1 reference

Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells

21 January 2018

1 reference

Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma

21 January 2018

1 reference

Arginine metabolism and nutrition in growth, health and disease

21 January 2018

1 reference

Polyamines and cancer: old molecules, new understanding

21 January 2018

1 reference

AMP-activated protein kinase attenuates nitric oxide-induced beta-cell death

21 January 2018

1 reference

Targeting eNOS in pancreatic cancer

21 January 2018

1 reference

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

21 January 2018

1 reference

Arginine deprivation as a new treatment strategy for head and neck cancer

21 January 2018

1 reference

Bridging epigenetics and metabolism: role of non-essential amino acids

21 January 2018

1 reference

Proline metabolism and microenvironmental stress

21 January 2018

1 reference

The proline regulatory axis and cancer

21 January 2018

1 reference

Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments

21 January 2018

1 reference

Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.

21 January 2018

1 reference

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

21 January 2018

1 reference

Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells

21 January 2018

1 reference

Defining macropinocytosis

21 January 2018

1 reference

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

21 January 2018

1 reference

Stromal biology of pancreatic cancer

21 January 2018

1 reference

Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy

21 January 2018

1 reference

Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

21 January 2018

1 reference

Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts

21 January 2018

1 reference

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells

21 January 2018

1 reference

The pancreas cancer microenvironment

21 January 2018

1 reference

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas

21 January 2018

1 reference

In vivo detection of citrate in brain tumors by 1H magnetic resonance spectroscopy at 3T.

21 January 2018

1 reference

Tumor M2-Pyruvate Kinase as Tumor Marker in Exocrine Pancreatic Cancer A Meta-Analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29501

1 reference

2 September 2017

1 reference